The product of ALPL is a membrane bound glycosylated enzyme that broadly participating in phosphatase activity and alkaline phosphatase activity, therefore, the alteration of ALPL is found to be associated with hypophosphatasia and prostate cancer bone metastasis [31,32]. The gene discussed is ALPL; the disease is prostate cancer.